IMMUNE-MEDIATED GASTROINTESTINAL DISORDER

This adverse event was reported 43 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED GASTROINTESTINAL DISORDER:

# Drug Count
0 IPILIMUMAB 17
1 NIVOLUMAB 17
2 CARBOPLATIN 8
3 OXALIPLATIN 5
4 TRASTUZUMAB 5
5 PACLITAXEL 4
6 GEMCITABINE 3
7 GEMCITABINE HYDROCHLORIDE 3
8 PREDNISONE 3
9 ADALIMUMAB 2
See all common drugs associated with IMMUNE-MEDIATED GASTROINTESTINAL DISORDER

IMMUNE-MEDIATED GASTROINTESTINAL DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIVOLUMAB AND RELATLIMAB-RMBW 1 0.0019
1 ROPEGINTERFERON ALFA-2B 1 0.0005
2 IPILIMUMAB 17 0.0004
3 NIVOLUMAB 17 0.0002
4 DURVALUMAB 2 0.0001
5 TRASTUZUMAB 5 0.0001
6 OXALIPLATIN 5 0.0001
7 CARBOPLATIN 8 0.0001
8 GEMCITABINE HYDROCHLORIDE 3 0.0001
9 PACLITAXEL 4 0.0000
See all drugs enriched for association with IMMUNE-MEDIATED GASTROINTESTINAL DISORDER